Patents by Inventor David Philip Elder

David Philip Elder has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7229640
    Abstract: A controlled release or delayed release formulation contains a selective serotonin reuptake inhibitor (SSRI) such as paroxtine.
    Type: Grant
    Filed: December 18, 2001
    Date of Patent: June 12, 2007
    Assignee: SmithKline Beecham p.l.c.
    Inventors: Graham Stanley Leonard, David Philip Elder
  • Patent number: 6969526
    Abstract: A controlled release or delayed release formulation contains a selective serotonin reuptake inhibitor (SSRI) such as paroxtine.
    Type: Grant
    Filed: December 18, 2001
    Date of Patent: November 29, 2005
    Assignee: SmithKline Beecham p.l.c.
    Inventors: Graham Stanley Leonard, David Philip Elder
  • Publication number: 20040247667
    Abstract: Invented are pharmaceutical compositions containing paroxetine methanesulfonate.
    Type: Application
    Filed: April 21, 2004
    Publication date: December 9, 2004
    Applicant: SmithKline Beecham p.l.c.
    Inventors: Ahmad Khalaf Al-Deeb Al-Ghazawi, Andrew Simon Craig, David Philip Elder, Victor Witold Jacewicz, David Alan Jones, Deirdre O'Keeffe, Padma Meneaud, Michael Urquhart, Neal Ward
  • Publication number: 20030203937
    Abstract: Invented are pharmaceutical compositions containing paroxetine methanesulfonate.
    Type: Application
    Filed: May 6, 2003
    Publication date: October 30, 2003
    Applicant: SmithKline Beecham p.l.c.
    Inventors: Ahmad Khalaf Al-Deeb Al-Ghazawi, Andrew Simon Craig, David Philip Elder, Victor Witold Jacewicz, David Alan Jones, Deirdre O'Keeffe, Meneaud Padma Patel, Michael Urquhart, Neal Ward
  • Publication number: 20030186938
    Abstract: A water-dispersible formulation of paroxetine for immediate oral administration comprises a dry blend of paroxetine, a water-soluble dispersing agent, and a taste-masking agent, as a dispersible powder or moulded into a tablet.
    Type: Application
    Filed: June 9, 2003
    Publication date: October 2, 2003
    Inventors: Ahmad Khalef Al-Deeb Al-Ghazawi, David Philip Elder, Padma Meneaud
  • Patent number: 6548084
    Abstract: A controlled release or delayed release formulation contains a selective serotonin reuptake inhibitor (SSRI) such as paroxetine.
    Type: Grant
    Filed: September 9, 1999
    Date of Patent: April 15, 2003
    Assignee: SmithKline Beecham plc
    Inventors: Graham Stanley Leonard, David Philip Elder
  • Publication number: 20020090394
    Abstract: A controlled release or delayed release formulation contains a selective serotonin reuptake inhibitor (SSRI) such as paroxtine.
    Type: Application
    Filed: December 18, 2001
    Publication date: July 11, 2002
    Applicant: SmithKline Beecham plc
    Inventors: Graham Stanley Leonard, David Philip Elder
  • Publication number: 20020028242
    Abstract: A controlled release or delayed release formulation contains a selective serotonin reuptake inhibitor (SSRI) such as paroxetine.
    Type: Application
    Filed: September 9, 1999
    Publication date: March 7, 2002
    Inventors: GRAHAM STANLEY LEONARD, DAVID PHILIP ELDER
  • Publication number: 20010023252
    Abstract: Invented are pharmaceutical compositions containing paroxetine methanesulfonate.
    Type: Application
    Filed: March 12, 2001
    Publication date: September 20, 2001
    Applicant: SmithKline Beecham Plc
    Inventors: Ahmad Khalaf Al-Deeb Al-Ghazawi, Andrew Simon Craig, David Philip Elder, Victor Witold Jacewicz, David Alan Jones, Deirdre O'Keeffe, Padma Meneaud Patel, Michael Urquhart, Neal Ward